This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Researchers from the University of Pavia in Italy analyzed the cost-effectiveness of ECG as a screening tool for long QT syndrome (LQTS) in the first month of life, between days 15 and 25. Based on their own data from 45,000 infants, they estimate the prevalence of LQTS to be ~1/2500.1 As an alternative, or surrogate, to a prospective randomized controlled study (that might be unethical and impractical), a complex decision tree analysis was performed. The measures were life years saved (LYS), numbers of lives saved (number of deaths prevented before age 40), and sustained costs (in Euros). Loss of productivity was not included. The expected survival of …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
